Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Jul 1;178(1):349-53.
doi: 10.1084/jem.178.1.349.

Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo

Affiliations

Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo

X Yang et al. J Exp Med. .

Abstract

Differential activation of CD4+ T cell subsets in vivo leads to the development of qualitatively different effector responses. We identify an approach that allows selective activation of strongly Th1-dominated immune responses to protein antigens. Whereas in vivo administration of ovalbumin (OVA) induces cytokine synthesis that is neither Th1 nor Th2 dominated, administration of glutaraldehyde polymerized, high relative molecular weight OVA (OA-POL) leads to 20-fold increase in the ratio of interferon gamma (IFN-gamma)/IL-4 and IFN-gamma/IL-10 synthesis observed after short-term, antigen-mediated restimulation directly ex vivo. In contrast, concurrent in vivo administration of anti-IFN-gamma mAb and OVA or OA-POL results in marked increases in IL-4 and IL-10, and decreased IFN-gamma production, reflecting a polarization of the response towards a Th2-like pattern of cytokine synthesis. These observations may be useful in clinical settings including hypersensitivity, autoimmune diseases, and vaccine development where the ability to actively select specific patterns of cytokine gene expression would be advantageous.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1973 May;110(5):1402-12 - PubMed
    1. J Immunol. 1993 Jan 15;150(2):361-6 - PubMed
    1. Immunochemistry. 1975 Jul;12(6-7):555-9 - PubMed
    1. J Immunol. 1988 Jun 15;140(12):4245-52 - PubMed
    1. J Cell Physiol. 1990 May;143(2):352-6 - PubMed

Publication types